Gender differences in stage distribution of bladder cancer

Urology

Volumn 55, Issue 3, 2000, Pages 368-371

  Mungan, N Aydin ^a   Kiemeney, Lambertus A L M ^a   Van Dijck, Jos A A M ^b   Van Der Poel, Henk G ^a   Witjes, J Alfred ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Oost   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BLADDER CANCER; CANCER REGISTRY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE BIOPSY; MALE; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; SARCOMA; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; SARCOMA; SEX FACTORS; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0033968965     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00481-1     Document Type: Article

References (19)

1. Fernandz F.A., Escudero G.C., Ruiz F.M., et al. Influencia de la diferencia de sexo en la agresividad biologica del tumor uretelial vesical en su primer diagnostica. Acta Urol Esp. 22:1998;34-36.
2. Kiemeney L.A.L.M., Coebergh J.W.W., Koper N.P., et al. Bladder cancer incidence and survival in the southeastern part of the Netherlands, 1975-1989. Eur J Cancer. 30A:1994;1134-1137.
3. Fleshner N.E., Herr H.W., Stewart A.K., et al. The national cancer data base report on bladder carcinoma. Cancer. 78:1996;1505-1513.
4. Kiemeney L.A.L.M., Straatman H., Witjes J.A. Decreasing bladder cancer mortality in the Netherlands. Br J Urol. 78:1996;686-690.
5. Koch M., McPhee M.S., Gaedke H., et al. Five year follow-up of patients with cancer of the bladder. The Northern Alberta experience. Clin Invest Med. 11:1988;253-258.
6. Timberg G., Rahu M., Gornoi K., et al. Bladder cancer in Estonia, 1968-1992 incidence, mortality, prevalence and survival . Scand J Urol Nephrol. 31:1997;337-342.
7. Berlie J., Janin M.L., Hucher M., et al. Mortalite par cancer de la vessie en France, de 1952 a 1976. Son evolation crossante et sa repartition geographique particuliere dans sud de la France. Bull Cancer. 66:1979;317-326.
8. Hermanek P., Sobin L.H. TNM Classification of Malignant Tumors. 4th ed. 1987;Springer-Verlag, Berlin.
9. Mommsen S., Aagaard J., Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol. 17:1983;163-167.
10. Kiemeney L.A.L.M., Witjes J.A., Verbeek A.L.M., et al. The clinical epidemiology of superficial bladder cancer. Br J Cancer. 67:1993;806-812.
11. Johansson S.L., Cohen S.M. Epidemiology and aetiology of bladder cancer. Semin Surg Oncol. 13:1997;291-298.
12. Lijinsky W., Thomas B.J., Kovatch R.M. Systemic and local carcinogenesis by directly acting N-nitroso compounds given to rats by intravesicular administration. Carcinogenesis. 13:1992;1101-1105.
13. Horn E.P., Tucker M.A., Lambert G., et al. A study of gender-based cytochrome p4501A2 variability a possible mechanism for the male excess of bladder cancer . Cancer Epidemiol Biomarkers Prev. 4:1995;529-533.
14. Cantor K.P., Lynch C.F., Johnson D. Bladder cancer, parity, and age at first birth. Cancer Causes Control. 3:1992;57-62.
15. Veneis P., Pirastu R. Aromatic amines and cancer. Cancer Causes Control. 8:1997;346-355.
16. Maralani S., Wood D.P., Grignon D., et al. Incidence of urethral involvement in female bladder cancer. Urology. 50:1997;537-541.
17. Anton-Culver H., Lee-Feldstein A., Taylor T.H. The association of bladder cancer risk with ethnicity, gender, and smoking. Ann Epidemiol. 3:1993;429-433.
18. Hartge P., Harvey E.B., Marston W. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst. 82:1990;1636-1640.
19. Ersig D., Elmajian D., Groshen S. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med. 331:1994;1259-1264.